Allan Kaspar
About Allan Kaspar
Allan Kaspar serves as the Vice President of Research Gene Therapy at Insmed Incorporated, a position he has held since 2021. He has extensive experience in the field, having previously worked at Pfizer, Androclus Therapeutics, and The Burnham Institute, and holds a PhD in immunology from Stanford University.
Work at Insmed
Allan Kaspar has served as Vice President of Research Gene Therapy at Insmed Incorporated since 2021. In this role, he oversees research initiatives focused on gene therapy, contributing to the company's mission of developing innovative treatments for serious diseases. His leadership in research aims to advance the understanding and application of gene therapy technologies within the organization.
Previous Experience at Pfizer
Allan Kaspar worked at Pfizer, Inc. for a total of seven years, holding the position of Principal Scientist from 2008 to 2013 and previously as a Scientist from 2006 to 2013. During his tenure, he contributed to various projects that advanced the company's research capabilities and product development in the pharmaceutical sector.
Educational Background
Allan Kaspar holds a PhD in immunology from Stanford University School of Medicine, where he studied from 1992 to 1999. He also earned a Bachelor of Science degree in Biology from the University of Illinois Urbana-Champaign from 1988 to 1992. Additionally, he obtained a Master of Business Administration (MBA) from San Diego State University, further enhancing his expertise in management within the scientific field.
Early Career Experience
Before his roles at Pfizer, Allan Kaspar worked as a Scientist at Androclus Therapeutics from 2004 to 2006 and as a Postdoctoral Fellow at The Burnham Institute from 2000 to 2001. These positions provided him with foundational experience in research and development, contributing to his expertise in gene therapy and immunology.